IL6 and COVID-19: • Significantly higher levels of IL-6, IL-8, and TNF-α were observed in serum of COVID-19 patients as compared to the healthy control or patients with multiple myeloma.• IL-6, IL-8, and TNF-α were associated with worst disease outcome and suggested as the predictive indicators of the disease.